Incorporation of Urinary Neutrophil Gelatinase-Associated Lipocalin and Computed Tomography Quantification to Predict Acute Kidney Injury and In-Hospital Death in COVID-19 Patients.

Journal: Kidney diseases (Basel, Switzerland)
Published Date:

Abstract

BACKGROUND: The prevalence of acute kidney injury (AKI) in COVID-19 patients is high, with poor prognosis. Early identification of COVID-19 patients who are at risk for AKI and may develop critical illness and death is of great importance.

Authors

  • Li He
    School of Minerals Processing and Bioengineering, Central South University, Changsha 410083, China.
  • Qunzi Zhang
    Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Ze Li
    Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Li Shen
    Department of Clinical Pharmacy, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
  • Jiayin Zhang
    Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Peng Wang
    Neuroengineering Laboratory, School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin, China.
  • Shan Wu
    Department of Endoscopy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Ting Zhou
    Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Qiuting Xu
    Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Xiaohua Chen
    Department of Infection, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Xiaohong Fan
    Department of Pneumology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Ying Fan
    Division of Clinical Review, Office of Safety and Clinical Evaluation, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
  • Niansong Wang
    Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Keywords

No keywords available for this article.